PubMed Health⌕ Search

Biomedical subjects

R Brigato

Publications and source records attributed to R Brigato.

11 recordsLinked to original sources
PubMedDate not supplied

[The therapy of plastic penile induration using superoxide dismutase per os and injection combined with vasoactive intracavernous pharmacotherapy].

The Authors report their experience of the treatment of IPP using injection and per os superoxide dismutase therapy associated with vasoactive FIC. Ninety carefully selected patients were included in the study. Although a complete recovery was not obtained, pain disappeared and incurvation improved in the majority of patients thus enabling normal sexual activity.

Administration, Oral↗
PubMedDate not supplied

[Our experience with the medico-sexual treatment of premature ejaculation].

The paper examines 66 cases of early ejaculation treated from January to December 1989. Following a short etiopathological review of the literature, the paper illustrates the therapeutical methods used and results obtained using a combined and interdisciplinary medical and sexological approach.

Adolescent↗
PubMedDate not supplied

[Intracavernous pharmacotherapy in men who have undergone cystectomy for neoplasia].

Impotentia erigendi is a consequence of radical surgery such as cystectomy due to neoplasia. It is caused by damage to neurovascular structures, and in particular to the nerve fibres of the sacral plexus. Current therapies include the use of penile prostheses or drug therapy. The paper reports the Authors' personal experience of the use of intracavernous drug therapy in 24 patients cystectomised due to vesical carcinoma. Objectively valid results were obtained in 33% of patients. No complications were observed and the treatment represents a valid alternative to mechanical prosthesis.

Aged↗
PubMedDate not supplied

[Cyproterone acetate in benign prostatic hypertrophy].

The literature reports that the use of an anti-androgen receptor like CPA is capable of reducing the epithelial component of BPH. The clinical results of the treatment carried out in 20 patients suffering from BPH with a prevalent epithelial component are presented.

Aged↗
PubMedDate not supplied

[Adjuvant therapy with vinblastine and interferon in metastatic renal carcinoma].

An integrated therapeutic approach was adopted to treat metastatic renal carcinoma, the reason being: 1) to effect a regression of metastasis that could not be attacked surgically either because of its location or extent; 2) to limit micrometastatic diffusion in patients with N+.0.05 mg/kg Vinblastine was used every three weeks in association with alfa-2A-IFN in a dose of 18 X 10(6) U 3 times a week. Included in this study were twelve patients with renal carcinoma subjected to nephrectomy with lymph nodal metastases and with or without remote M+. Without drawing hasty conclusions, this therapy can be said to have a useful role after correct surgical approach.

Bone Neoplasms↗
PubMedDate not supplied

[Adjuvant M-VEC in advanced urotheliomas of the bladder].

The therapeutic efficacy of chemotherapy in bladder's carcinoma is today supported by many statistical reports; the response rates are ranging from 35% to 45%. Results of the treatment with adjuvant chemotherapy (M-VEC in 22 patients with or without metastatic tumor are presented. Favourable objective responses were seen in 25% of the patients. The conclusion is drawn that this therapy is very useful in the treatment of metastatic diseases, but it can be used also in non-metastatic (M0) patients to prevent the growth of micrometastasis.

Aged↗
PubMedDate not supplied

[A rare case of bilateral granulomatous orchitis].

A rare case of bilateral granulomatous orchitis is presented and the problems of diagnosis and treatment are discussed. There are no relationships between echography and granulomatous orchitis. At present, granulomatous orchitis remains a disease with a difficult etiology treatment.

Diagnosis, Differential↗